Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$109.89

3.26 (3.06%)

04:55
12/17/19
12/17
04:55
12/17/19
04:55

GW Pharmaceuticals management to meet with Oppenheimer

Meetings to be held in Europe on December 16-17 hosted by Oppenheimer.

  • 17

    Dec

GWPH GW Pharmaceuticals
$109.89

3.26 (3.06%)

11/04/19
PIPR
11/04/19
NO CHANGE
Target $210
PIPR
Overweight
Piper says GW Pharmaceuticals shares could react well to even slight Q3 beat
Piper Jaffray analyst Danielle Brill said she thinks Q3 revenues from GW Pharmaceuticals, which reports tomorrow, should surpass her $84.8M revenue estimate and that "even a slight" beat should benefit the stock as it will increase investors' confidence that Epidiolex growth continues to be robust beyond the initial bolus effect that came with the product's launch. She also notes the stock is down 18% since the company's Q2 earnings, compared to a 5% advance for the iShares Nasdaq Biotechnology Index (IBB) over the same time. Brill keeps an Overweight rating and $210 price target on shares of GW Pharmaceuticals.
11/06/19
PIPR
11/06/19
NO CHANGE
Target $160
PIPR
Overweight
Piper cuts GW Pharmaceuticals target to $160 but says selloff overdone
Piper Jaffray analyst Danielle Brill lowered her price target for GW Pharmaceuticals to $160 from $210 saying the ceiling for Epidiolex may be lower than originally projected due to patient discontinuations. However, she does "not think we're close to hitting a plateau" following GW's Q3 results. In the midterm, the analyst expects the ongoing European launch, additional off-label usage and label expansion into the tuberous sclerosis complex to serve as primary drivers of growth. Brill, who lowered her peak sales estimate for Epidiolex to $1.5B from $2.0B, believes the 12% post-earnings selloff in shares of GW Pharmaceuticals is overdone. Continued growth over the coming quarters should "restore confidence and drive shares higher," she says. The analyst keeps an Overweight rating on the stock.
11/06/19
OPCO
11/06/19
NO CHANGE
Target $222
OPCO
Outperform
GW Pharmaceuticals price target lowered to $222 from $233 at Oppenheimer
Oppenheimer analyst Esther Rajavelu lowered her price target for GW Pharmaceuticals to $222 following the company's quarterly results, saying Q3 revenues were in line with estimates. Though GW Pharmaceuticals met her Q3 topline expectations, Rajavelu tells investors in a research note that she is lowering Epidiolex revenue estimates for future periods as she anticipates moderating new patient numbers and higher attrition rates. She keeps an Outperform rating on the shares, as she continues to believe Epidiolex use in multiple seizure types is not fully reflected in the stock at current levels.
11/06/19
MSCO
11/06/19
NO CHANGE
Target $231
MSCO
Overweight
Morgan Stanley a buyer of GW Pharmaceuticals on any post-earnings weakness
Morgan Stanley analyst David Lebowitz said GW Pharmaceuticals' U.S. Epidiolex sales of about $86M in Q3 "ultimately is a strong number that supports long-term projections," but it also is likely short of investors' high expectation following "dramatic beats" posted in the first two full quarters of the drug being on the market. Epidiolexhas been prescribed by over 3,000 physicians, which is up from 2,500, and the target prescribing base remains 6,000, noted Lebowitz. He would be a buyer on any weakness given his unchanged view on the drug's long-term prospects and keeps an Overweight rating on GW shares with a slightly lowered price target of $231, down from $233.

TODAY'S FREE FLY STORIES

CBIO

Catalyst Biosciences

$7.34

0.07 (0.96%)

08:11
01/17/20
01/17
08:11
01/17/20
08:11
Hot Stocks
Catalyst Biosciences appoints Geoffrey Shiu Fei Ling, Sharon Tetlow to board »

Catalyst Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:10
01/17/20
01/17
08:10
01/17/20
08:10
Conference/Events
Wolfe Research industrials analysts to hold an analyst/industry webcast »

Multi-Idndustry Analyst…

TXT

Textron

$45.97

0.635 (1.40%)

, BDRBF

Bombardier

$0.00

(0.00%)

08:10
01/17/20
01/17
08:10
01/17/20
08:10
Recommendations
Textron, Bombardier analyst commentary  »

Textron could make…

TXT

Textron

$45.97

0.635 (1.40%)

BDRBF

Bombardier

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 13

    Feb

ETFC

E-Trade

$46.56

0.36 (0.78%)

08:10
01/17/20
01/17
08:10
01/17/20
08:10
Hot Stocks
E-Trade chief risk officer Paul Brandow to retire, Brent Simonich to succeed »

E-Trade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 26

    Feb

UMH

UMH Properties

$16.39

0.26 (1.61%)

08:07
01/17/20
01/17
08:07
01/17/20
08:07
Hot Stocks
UMH Properties expands board to 11 with appointment of Amy Lynn Butewicz »

UMH Properties announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBCP

Independent Bank

$22.77

0.2 (0.89%)

08:07
01/17/20
01/17
08:07
01/17/20
08:07
Downgrade
Independent Bank rating change  »

Independent Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

  • 19

    Feb

CURLF

Curaleaf Holdings

$0.00

(0.00%)

08:06
01/17/20
01/17
08:06
01/17/20
08:06
Hot Stocks
Curaleaf Holdings provides update on three acquisitions »

Curaleaf Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:06
01/17/20
01/17
08:06
01/17/20
08:06
Conference/Events
Wolfe Research energy analysts to hold a weekly analyst/industry webcast »

Energy Analysts…

TXN

Texas Instruments

$130.17

1 (0.77%)

, MCHP

Microchip

$108.72

1.17 (1.09%)

08:06
01/17/20
01/17
08:06
01/17/20
08:06
Recommendations
Texas Instruments, Microchip, Broadcom, ON Semiconductor analyst commentary  »

Citi sees Semi estimates…

TXN

Texas Instruments

$130.17

1 (0.77%)

MCHP

Microchip

$108.72

1.17 (1.09%)

AVGO

Broadcom

$306.99

3.86 (1.27%)

ON

ON Semiconductor

$25.03

0.16 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 03

    Feb

RMR

RMR Group

$45.23

0.8 (1.80%)

, DHC

Diversified Healthcare Trust

$8.79

0.085 (0.98%)

08:06
01/17/20
01/17
08:06
01/17/20
08:06
Hot Stocks
RMR Group announces 19,764 sq. ft. of leasing in Texas »

RMR Group (RMR) announced…

RMR

RMR Group

$45.23

0.8 (1.80%)

DHC

Diversified Healthcare Trust

$8.79

0.085 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

KSU

Kansas City Southern

$161.80

2.07 (1.30%)

08:06
01/17/20
01/17
08:06
01/17/20
08:06
Earnings
Kansas City Southern reports Q4 adj. EPS $1.82, consensus $1.84 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

MGPI

MGP Ingredients

$52.90

0.74 (1.42%)

08:05
01/17/20
01/17
08:05
01/17/20
08:05
Earnings
MGP Ingredients sees FY19 EPS $2.20-$2.30, two est. $2.57 »

Reports preliminary FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:05
01/17/20
01/17
08:05
01/17/20
08:05
General news
U.S. housing starts preview: starts sh »

U.S. housing starts…

BE

Bloom Energy

$9.27

-0.47 (-4.83%)

08:04
01/17/20
01/17
08:04
01/17/20
08:04
Hot Stocks
Bloom Energy announces legal victory in Santa Clara, California »

Bloom Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTN

Vail Resorts

$249.08

3.76 (1.53%)

08:03
01/17/20
01/17
08:03
01/17/20
08:03
Hot Stocks
Vail Resorts backs FY20 Resort Reported EBITDA guidance »

Given the strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

BSRR

Sierra Bancorp

$27.75

0.25 (0.91%)

08:03
01/17/20
01/17
08:03
01/17/20
08:03
Hot Stocks
Sierra Bancorp raises quarterly dividend by 1c to 20c per share »

Sierra Bancorp, parent of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$4.69

-0.03 (-0.64%)

, MNLO

Menlo Therapeutics

$6.73

-0.28 (-3.99%)

08:03
01/17/20
01/17
08:03
01/17/20
08:03
Hot Stocks
Foamix announces OrbiMed's support of Menlo Therapeutics merger »

Foamix Pharmaceuticals…

FOMX

Foamix

$4.69

-0.03 (-0.64%)

MNLO

Menlo Therapeutics

$6.73

-0.28 (-3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 06

    Feb

  • 02

    Jun

MTN

Vail Resorts

$249.08

3.76 (1.53%)

08:02
01/17/20
01/17
08:02
01/17/20
08:02
Hot Stocks
Vail Resorts reports season-to-date total lift ticket revenue up 0.4% »

Vail Resorts reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

NFRMY

Nufarm

$0.00

(0.00%)

08:00
01/17/20
01/17
08:00
01/17/20
08:00
Downgrade
Nufarm rating change  »

Nufarm downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$228.90

4.29 (1.91%)

08:00
01/17/20
01/17
08:00
01/17/20
08:00
Options
Home Depot call buyer realizes 189% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

WING

Wingstop

$87.67

-3.78 (-4.13%)

08:00
01/17/20
01/17
08:00
01/17/20
08:00
Hot Stocks
Wingstop targets mid-single digit SSS growth over the next 3-5 years »

As part of its Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWCMY

Alumina

$0.00

(0.00%)

07:58
01/17/20
01/17
07:58
01/17/20
07:58
Initiation
Alumina initiated  »

Alumina initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$46.86

0.56 (1.21%)

07:55
01/17/20
01/17
07:55
01/17/20
07:55
Recommendations
Comcast analyst commentary  »

Comcast taking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

PLAY

Dave & Buster's

$42.05

-0.13 (-0.31%)

07:49
01/17/20
01/17
07:49
01/17/20
07:49
Hot Stocks
Dave & Buster's up 12% after KKR raises stake, says will discuss strategy »

Shares of Dave &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

STT

State Street

$81.01

-0.215 (-0.26%)

07:47
01/17/20
01/17
07:47
01/17/20
07:47
Hot Stocks
Breaking Hot Stocks news story on State Street »

State Street up 4% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 31

    Jan

  • 26

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.